These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35927740)

  • 1. A randomized controlled trial of customized adherence enhancement (CAE-E): study protocol for a hybrid effectiveness-implementation project.
    Levin JB; Briggs F; Blixen C; Bauer M; Einstadter D; Albert JM; Weise C; Woods N; Fuentes-Casiano E; Cassidy KA; Rentsch J; Sarna K; Sajatovic M
    Trials; 2022 Aug; 23(1):634. PubMed ID: 35927740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using mHealth to improve adherence and reduce blood pressure in individuals with hypertension and bipolar disorder (iTAB-CV): study protocol for a 2-stage randomized clinical trial.
    Levin JB; Moore DJ; Depp C; Montoya JL; Briggs F; Rahman M; Stange KC; Einstadter D; Weise C; Conroy C; Yala J; Radatz E; Sajatovic M
    Trials; 2022 Jun; 23(1):539. PubMed ID: 35768875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 6-Month, Prospective, Randomized Controlled Trial of Customized Adherence Enhancement Versus Bipolar-Specific Educational Control in Poorly Adherent Individuals With Bipolar Disorder.
    Sajatovic M; Tatsuoka C; Cassidy KA; Klein PJ; Fuentes-Casiano E; Cage J; Aebi ME; Ramirez LF; Blixen C; Perzynski AT; Bauer MS; Safren SA; Levin JB
    J Clin Psychiatry; 2018 Sep; 79(6):. PubMed ID: 30256551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting medication adherence among patients with bipolar disorder: a multicenter randomized controlled trial of a multifaceted intervention.
    Pakpour AH; Modabbernia A; Lin CY; Saffari M; Ahmadzad Asl M; Webb TL
    Psychol Med; 2017 Oct; 47(14):2528-2539. PubMed ID: 28446253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder.
    Sajatovic M; Levin J; Tatsuoka C; Micula-Gondek W; Fuentes-Casiano E; Bialko CS; Cassidy KA
    Bipolar Disord; 2012 May; 14(3):291-300. PubMed ID: 22548902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Customized adherence enhancement for individuals with bipolar disorder receiving antipsychotic therapy.
    Sajatovic M; Levin J; Tatsuoka C; Micula-Gondek W; Williams TD; Bialko CS; Cassidy KA
    Psychiatr Serv; 2012 Feb; 63(2):176-8. PubMed ID: 22302337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A customized adherence enhancement program for adolescents and young adults with suboptimal adherence and bipolar disorder: Trial design and methodological report.
    McVoy M; Delbello M; Levin J; Modi AC; Forthun LF; Briggs F; Appling D; Broadnax M; Conroy C; Cooley R; Eapen G; Sajatovic M
    Contemp Clin Trials; 2022 Apr; 115():106729. PubMed ID: 35278693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing medication adherence in patients with bipolar disorder.
    Berk L; Hallam KT; Colom F; Vieta E; Hasty M; Macneil C; Berk M
    Hum Psychopharmacol; 2010 Jan; 25(1):1-16. PubMed ID: 20041478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-Related Differences in Medication Adherence, Symptoms, and Stigma in Poorly Adherent Adults With Bipolar Disorder.
    Smilowitz S; Aftab A; Aebi M; Levin J; Tatsuoka C; Sajatovic M
    J Geriatr Psychiatry Neurol; 2020 Sep; 33(5):250-255. PubMed ID: 31542988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Acting Injectable Antipsychotic Medication Plus Customized Adherence Enhancement in Poor Adherence Patients With Bipolar Disorder.
    Sajatovic M; Levin JB; Ramirez LF; Cassidy KA; McNamara N; Fuentes-Casiano E; Wilson B; Appling D; S FB
    Prim Care Companion CNS Disord; 2021 Sep; 23(5):. PubMed ID: 34534421
    [No Abstract]   [Full Text] [Related]  

  • 11. Daily electronic monitoring of subjective and objective measures of illness activity in bipolar disorder using smartphones--the MONARCA II trial protocol: a randomized controlled single-blind parallel-group trial.
    Faurholt-Jepsen M; Vinberg M; Frost M; Christensen EM; Bardram J; Kessing LV
    BMC Psychiatry; 2014 Nov; 14():309. PubMed ID: 25420431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 6-month, prospective, randomized controlled trial of customized adherence enhancement versus a bipolar-specific educational control in poorly adherent adolescents and young adults living with bipolar disorder.
    Levin JB; DelBello M; Modi AC; Briggs F; Forthun LF; McVoy M; Yala J; Cooley R; Black J; Conroy C; Sajatovic M
    Bipolar Disord; 2024 Nov; 26(7):696-707. PubMed ID: 39231780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illness experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication.
    Sajatovic M; Levin J; Fuentes-Casiano E; Cassidy KA; Tatsuoka C; Jenkins JH
    Compr Psychiatry; 2011; 52(3):280-7. PubMed ID: 21497222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trajectories of medication attitudes and adherence behavior change in non-adherent bipolar patients.
    Levin JB; Tatsuoka C; Cassidy KA; Aebi ME; Sajatovic M
    Compr Psychiatry; 2015 Apr; 58():29-36. PubMed ID: 25617964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An interventional pilot of customized adherence enhancement combined with long-acting injectable antipsychotic medication (CAE-L) for poorly adherent patients with chronic psychotic disorder in Tanzania.
    Mbwambo J; Kaaya S; Lema I; Burant CJ; Magwiza C; Madundo K; Njiro G; Blixen CE; Cassidy KA; Levin JB; Sajatovic M
    BMC Psychiatry; 2022 Jan; 22(1):62. PubMed ID: 35086504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing the rate and duration of Re-ADMISsions among patients with unipolar disorder and bipolar disorder using smartphone-based monitoring and treatment - the RADMIS trials: study protocol for two randomized controlled trials.
    Faurholt-Jepsen M; Frost M; Martiny K; Tuxen N; Rosenberg N; Busk J; Winther O; Bardram JE; Kessing LV
    Trials; 2017 Jun; 18(1):277. PubMed ID: 28619114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective trial of customized adherence enhancement plus long-acting injectable antipsychotic medication in homeless or recently homeless individuals with schizophrenia or schizoaffective disorder.
    Sajatovic M; Levin J; Ramirez LF; Hahn DY; Tatsuoka C; Bialko CS; Cassidy KA; Fuentes-Casiano E; Williams TD
    J Clin Psychiatry; 2013 Dec; 74(12):1249-55. PubMed ID: 24434094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.